.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Idiopathic Granulomatous Mastitis (IGM) is a chronic inflammatory breast condition that frequently relapses. Clinicians often struggle to predict which patients will face a return of symptoms. However, recent findings suggest that the M-score IGM recurrence correlation offers a vital prognostic tool. By quantifying symptom severity at the initial diagnosis, medical professionals can better identify high-risk individuals.
Researchers analyzed 90 patients with histopathologically confirmed IGM. They utilized the M-score to provide objective data on clinical severity. The results showed a significant link between initial scores and future relapse. For instance, patients presenting with abscesses had a recurrence rate of 93.18%. In contrast, those without abscesses only saw a 60.87% recurrence rate. Furthermore, the data indicates that higher initial scores correlate strongly with a higher probability of relapse.
The study highlights that higher initial M-scores directly correspond to increased disease recurrence. Consequently, this scoring system helps surgeons and gynecologists tailor follow-up protocols. Physicians should implement aggressive monitoring for patients with elevated scores or abscess formation. Using these objective metrics improves patient counseling and long-term care strategies. Additionally, clinicians can better allocate resources to patients who require intensive therapy.
The M-score provides an objective measure of symptom severity in Idiopathic Granulomatous Mastitis. It helps clinicians predict the likelihood of disease recurrence and evaluate treatment responses more accurately.
Abscesses significantly increase the risk of disease relapse. According to recent research, patients with abscesses faced a recurrence rate of over 93%, compared to approximately 61% for those without.
IGM is a chronic, inflammatory condition prone to relapses. Predicting recurrence allows doctors to implement more intensive follow-up and adjust treatment plans early to manage high-risk cases effectively.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional clinical judgment. Refer to the latest local and national guidelines for clinical practice.
References
Ötegeçeli MA et al. Can M-score be used to predict recurrence in IGM patients? Eur J Med Res. 2026 Feb 14. doi: 10.1186/s40001-026-04053-0. PMID: 41691333.
Yilmaz T, Gurel B, et al. Scoring Idiopathic Granulomatous Mastitis: An Effective System for Predicting Recurrence? Eur J Breast Health. 2018; 14(2): 112–116.
Akcan A, et al. Factors Associated with Recurrence in Idiopathic Granulomatous Mastitis. J Invest Surg. 2019.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New study finds initial M-scores and abscess presence significantly predict the risk of recurrence in Idiopathic Granulomatous Mastitis patients....
6 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
